SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-Oct-24 4:44 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 07-Oct-24 | Sale (Planned) | 76,920 | $0.56 | $43,306.00 | (17%) 464.95K to 388.03K | |
08-Oct-24 4:44 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 04-Oct-24 | Grant | 230,645 | -- | -- | 98% 234.3K to 464.95K | |
11-Mar-24 5:20 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 11-Mar-24 | Sale | 14,235 | $0.88 | $12,552.40 | (6%) 248.54K to 234.3K | |
12-Feb-24 5:23 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 12-Feb-24 | Sale | 787 | $1.01 | $792.67 | (< 1%) 249.32K to 248.54K | |
03-Nov-23 4:39 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 01-Nov-23 | Sale (Planned) | 67,695 | $0.73 | $49,417.40 | (21%) 317.02K to 249.32K | |
02-Nov-23 4:59 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 31-Oct-23 | Grant | 230,645 | -- | -- | 267% 86.37K to 317.02K | |
13-Mar-23 4:48 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 10-Mar-23 | Sale | 16,806 | $0.84 | $14,117.00 | (16%) 103.18K to 86.37K | |
15-Feb-23 5:13 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 13-Feb-23 | Sale | 928 | $0.93 | $863.04 | (< 1%) 104.11K to 103.18K | |
01-Mar-22 4:09 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 01-Mar-22 | Grant | 97,000 | -- | -- | 1365% 7.11K to 104.11K | |
14-Feb-22 10:00 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 11-Feb-22 | Payment of Exercise | 928 | -- | -- | (12%) 8.04K to 7.11K | |
25-Mar-21 5:07 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 24-Mar-21 | Grant | 8,035 | -- | -- | 100% 0 to 8.04K |